ADNRX Mutual Fund

NAV$21.22

Returns Overview

1 Month
-0.92%
3 Months
+21.02%
6 Months
+6.70%
YTD
+4.87%
1 Year
+17.01%
3 Years (annualized)
+23.28%
5 Years (annualized)
-12.09%

Risk Metrics (1-Year)

No risk data available for this Mutual Fund

Stress Test Scenarios

How would ADNRX have held up?
🦠COVID-19 Crash33 days
Market peak to trough during pandemic sell-off
Run Analysis
📈2022 Rate Hikes9 months
Fed aggressive rate hiking cycle bear market
PROUpgrade to run
📉2018 Q4 Selloff3 months
Trade war fears and Fed tightening
PROUpgrade to run
🏦SVB / Banking Crisis5 days
Regional banking contagion fears
PROUpgrade to run

1 Month Performance

Loading chart data...

3 Months Performance

Loading chart data...

6 Months Performance

Loading chart data...

1 Year Performance

Loading chart data...

Benchmark & Peers

Benchmark
S&P 500 Index(SPX)
This Mutual Fund (YTD)
+4.87%
Peer Avg (YTD)
+10.82%
vs Peers
-5.95%

ADNRX Mutual Fund Performance

ADNRX performance across multiple time periods: 1-month -0.92%, YTD 4.87%, 1-year 17.01%, 3-year 23.28%, 5-year -12.09%.

ADNRX returns trail the peer average of 10.82% YTD. With an expense ratio of 1.05%, investors should weigh costs against performance when evaluating this mutual fund.

ADNRX performance comparison shows side-by-side returns with another fund. ADNRX alternatives are available in the Mutual Fund Screener.